Theravance Biopharma, Inc. 4
4 · Theravance Biopharma, Inc. · Filed Oct 10, 2014
Insider Transaction Report
Form 4
BLUM LEONARD M
Sr VP, Chief Comm. Officer
Transactions
- Award
Share Option (Right to Buy)
2014-10-08+170,000→ 170,000 totalExercise: $22.00Exp: 2024-10-07→ Ordinary Shares (170,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable as follows: (a) with respect to the first 25% of the Company's shares subject to the option on October 1, 2015, subject to the optionee's continuous service through such date and (b) with respect to an additional 1/48th of the Company's shares subject to the option when the optionee completes each month of continuous service thereafter. The option shall be fully vested and exercisable on October 1, 2018 provided the optionee remains in continuous service with the Company through such date.